Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00668902 · ClinicalTrials.gov registry record · NA
Rapid Screening Phenotype Test To Evaluate CYP 2C19 Enzyme Activity Using Stable Isotope [13C]Pantoprazole
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT00668902 is a NA study that has completed, run by Indiana University. The registered enrollment target is 25 participants.
The verdict
NCT00668902, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the function of an enzyme that breaks down drugs and helps the removal of drugs from your body. This enzyme is called cytochrome P450 2C19 and is located in your liver. Exposure to other medications or variations in genes that you have inherited from your parents, may speed up or slow the function of this enzyme. As a result, some patients may develop unwanted effects from a drug while some other patients may not get benefit from taking the same drug. The aim of this study is to determine the function of this enzyme in your liver. We will do this by performing a series of breath tests and blood samples after you take pantoprazole. Pantoprazole is approved as an oral and intravenous drug by the Food and Drug Administration (FDA).
Interventions
- DRUG [13C]Pantoprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00668902
The ClinicalTrials.gov registry entry for NCT00668902 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [13C]Pantoprazole is the first listed.
NCT00668902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00668902 about?
NCT00668902 is a clinical study titled "Rapid Screening Phenotype Test To Evaluate CYP 2C19 Enzyme Activity Using Stable Isotope [13C]Pantoprazole". The purpose of this study is to determine the function of an enzyme that breaks down drugs and helps the removal of drugs from your body. This enzyme is called cytochrome P450 2C19 and is located in your liver. Exposure to other medications or variations in genes that you have inherited from your pa...
What is the current status of trial NCT00668902?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2007-03. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00668902?
The interventions under investigation include: [13C]Pantoprazole (DRUG).
Who is sponsoring clinical trial NCT00668902?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.